Institutional investors hold a majority ownership of ILMN through the 98.21% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended June 2014, these large investors purchased a net $5.3 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FEDERATED GLOBAL INVESTMENT MANA... Bought 1.1 Million shares of Illumina Inc
POINTSTATE CAPITAL LP Bought 761.6 Thousand shares of Illumina Inc
MATRIX CAPITAL MANAGEMENT LLC Bought 700.0 Thousand shares of Illumina Inc